These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8356762)

  • 1. [The effect of serum monitoring on concentration of perphenazine and zuclopenthixole].
    Thomsen K; Olesen OV; Poulsen JH
    Ugeskr Laeger; 1993 Aug; 155(32):2443-8. PubMed ID: 8356762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy control of perphenazine. 2. Clinical aspects].
    Kjeldsen CS; Larsen NE; Kragh-Sørensen P; Andersen E; Brøsen K; Gerholt F; Glue P; Hørder M; Klitgaard NA; Krarup G
    Ugeskr Laeger; 1991 Aug; 153(34):2339-43. PubMed ID: 1897043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of linearity of kinetics for the neuroleptics perphenazine and zuclopenthixol.
    Linnet K
    Eur J Clin Pharmacol; 1997; 52(4):317-8. PubMed ID: 9248772
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy control of perphenazine in paranoid conditions. 1. Organizational aspects].
    Rask PH; Krarup G; Kragh-Sørensen P; Andersen E; Brøsen K; Gerholt F; Glue P; Hørder M; Kjeldsen CS; Klitgaard NA
    Ugeskr Laeger; 1991 Aug; 153(34):2336-9. PubMed ID: 1897042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CYP2D6 genotype predicts the oral clearance of the neuroleptic agents perphenazine and zuclopenthixol.
    Jerling M; Dahl ML; Aberg-Wistedt A; Liljenberg B; Landell NE; Bertilsson L; Sjöqvist F
    Clin Pharmacol Ther; 1996 Apr; 59(4):423-8. PubMed ID: 8612387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of the isomers of clopenthixol in patients given cis(Z)-clopenthixol or cis(Z)/trans(E)-clopenthixol.
    Aaes-Jørgensen T; Gravem A; Jørgensen A
    Acta Psychiatr Scand Suppl; 1981; 294():70-7. PubMed ID: 6951396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic drug monitoring of patients on risperidone depot.
    Nesvåg R; Tanum L
    Nord J Psychiatry; 2005; 59(1):51-5. PubMed ID: 16195099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of the optimal perphenazine decanoate dose based on blood samples drawn within the first three weeks.
    Larsen NE; Hansen LB
    Ther Drug Monit; 1989 Nov; 11(6):642-6. PubMed ID: 2595744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the kinetic interactions of the neuroleptics perphenazine and zuclopenthixol with tricyclic antidepressives.
    Linnet K
    Ther Drug Monit; 1995 Jun; 17(3):308-11. PubMed ID: 7624929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appropriateness of therapeutic drug monitoring for lithium.
    Ratanajamit C; Soorapan S; Doang-ngern T; Waenwaisart W; Suwanchavalit L; Suwansiri S; Jantasaro S; Yanate I
    J Med Assoc Thai; 2006 Nov; 89(11):1954-60. PubMed ID: 17205880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clopenthixol decanoate and perphenazine enanthate in schizophrenic patients. A double-blind Nordic multicentre trial.
    Ahlfors UG; Dencker SJ; Gravem A; Remvig J
    Acta Psychiatr Scand Suppl; 1980; 279():77-91. PubMed ID: 6996426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry.
    Baumann P; Hiemke C; Ulrich S; Eckermann G; Gaertner I; Gerlach M; Kuss HJ; Laux G; Müller-Oerlinghausen B; Rao ML; Riederer P; Zernig G;
    Pharmacopsychiatry; 2004 Nov; 37(6):243-65. PubMed ID: 15551191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic drug monitoring of tricyclic antidepressants: how does it work under clinical conditions?
    Müller MJ; Dragicevic A; Fric M; Gaertner I; Grasmäder K; Härtter S; Hermann E; Kuss HJ; Laux G; Oehl W; Rao ML; Rollmann N; Weigmann H; Weber-Labonte M; Hiemke C
    Pharmacopsychiatry; 2003 May; 36(3):98-104. PubMed ID: 12806567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum concentrations of cis(Z)- and trans(E)-clopenthixol after administration of cis(Z)-clopenthixol and clopenthixol to human volunteers.
    Aaes-Jørgensen T
    Acta Psychiatr Scand Suppl; 1981; 294():64-9. PubMed ID: 6951395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluctuation of serum zuclopenthixol concentrations in patients treated with zuclopenthixol decanoate in viscoleo.
    Poulsen JH; Olesen OV; Larsen NE
    Ther Drug Monit; 1994 Apr; 16(2):155-9. PubMed ID: 8009563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase in weight after treatment with depot neuroleptics.
    Korsgaard S; Skausig OB
    Acta Psychiatr Scand; 1979 Feb; 59(2):139-44. PubMed ID: 420033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steady-state serum concentrations of the neuroleptic perphenazine in relation to CYP2D6 genetic polymorphism.
    Linnet K; Wiborg O
    Clin Pharmacol Ther; 1996 Jul; 60(1):41-7. PubMed ID: 8689810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum concentrations of the isomers of clopenthixol and a metabolite in patients given cis(Z)-clopenthixol decanoate in viscoleo.
    Aaes-Jørgensen T; Kirk L; Petersen E; Danneskiold-Samsøe P; Jørgensen A
    Psychopharmacology (Berl); 1983; 81(1):68-72. PubMed ID: 6415733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. III. Serum levels.
    Jrgensen A; Overø KF
    Acta Psychiatr Scand Suppl; 1980; 279():41-54. PubMed ID: 6931472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic drug monitoring of haloperidol, perphenazine, and zuclopenthixol in serum by a fully automated sequential solid phase extraction followed by high-performance liquid chromatography.
    Angelo HR; Petersen A
    Ther Drug Monit; 2001 Apr; 23(2):157-62. PubMed ID: 11294517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.